COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants

Nearly 90% of people taking immunosuppressants to treat autoimmune conditions produce an antibody response to COVID-19 vaccination, but the response is weaker than those of healthy people, according to a School of Medicine study.

Town halls set for community input on strategic plan

As the university’s strategic planning process continues, those building recommendations want to hear from more of the university community. Three virtual town halls will take place next week.

Memories of 9/11: shock, confusion and fear

In many respects, Washington University was lucky. The city was spared and, in the end, no student lost a close family member in the attacks. Still, students suffered.

Why do brief lung infections lead to lasting damage?

School of Medicine scientists have found clues to just how lung damage develops in the aftermath of a respiratory infection. The findings, in mice, reveal potential points of intervention to prevent chronic lung damage caused by viral infections.

WashU Experts on what has changed since 9/11

Historian Krister Knapp in Arts & Sciences and immigration expert Katie Meyer at the School of Law offer analysis in their disciplines on how the Sept. 11 attacks changed various aspects of life and policies in the United States.

Research Wire

The McKelvey School of Engineering’s Nathaniel Huebsch will use a nearly $2 million grant from the National Institutes of Health (NIH) to study hypertrophic cardiomyopathy, the most common cause of sudden death in young people.

Notables

The Washington University Review of Philosophy, a new annual journal of professional philosophy edited by undergraduate students, has published its inaugural issue.

Announcements

New programs to help faculty return to the classroom

The Office of the Provost has launched “Return and Reset,” a collection of programs and resources designed to help faculty navigate the new academic year. Programming kicks off Wednesday, Sept. 15.